Clinical Trial

The DISCOVER Study

Name: The DISCOVER Study — clinical trial record (NCT07390643)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: DISCOVERY

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this research study is to evaluate the possible benefits of screening with an investigational, but commercially available blood test designed to detect many types of cancer. The name of the screening blood test being studied is: -GRAIL Galleri MCED test

Trial Details

NCT Number	NCT07390643
Lead Sponsor	Dana-Farber Cancer Institute
Conditions	Cancer, Cancer Diagnosis
Enrollment	100 participants
Start Date	2026-07
Primary Completion	2027-01-31 (estimated)
Study Completion	2028-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-05